GLP-1 weight-loss drugs alter brain circuits in the amygdala and dopamine system to reduce the motivation to seek out high-calorie foods.
Scientists have identified a protective brain pathway that may help slow the progression of Parkinson's disease by ...
Parkinson’s disease is one of the most common brain disorders linked to aging. The disease affects movement, balance, muscle ...
For decades, dopamine signaling was viewed primarily through the lens of motor vigor—how fast or forcefully one moves. However, a landmark 2025 study from Karolinska Institutet published in Nature ...
Tavapadon may delay levodopa use in early Parkinson’s and help stabilize dosing in the later stages of the disease, with most patients avoiding initiation or dose increases.
Mount Sinai researchers have discovered distinct roles for two dopamine receptors located on nerve cells within the portion of the brain that controls approach vs. avoidance behavior. These receptors ...
During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...
Dopamine agonists are medications that mimic the effects of dopamine, which can be helpful if you have low dopamine levels. Dopamine is a complex and key neurotransmitter responsible for many of our ...
Can the function of just one small group of chemicals really determine whether you are happy or sad? Two neurotransmitters, dopamine and norepinephrine, called catecholamines, may do exactly that and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results